Thanks @ValerieVaughnMD et al for highlighting the importance of antibiotic stewardship in the time of COVID-19! #goblue
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
🔬Importante! La confección bacteriana es muy poco frecuente al momento de la admisión por COVID-19. El resultado en el día de la PCR para SARS-CoV-2 puede reducir la necesidad de iniciar tratamiento antimicrobiano empírico. #IDTwitter #Covid_19 https://t.c
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @DrKerbel: Congratulations @Payal_Patel. Important info for Abx Stewardship & Sepsis Large multicenter cohort of pts hospitalized with…
Congratulations @Payal_Patel. Important info for Abx Stewardship & Sepsis Large multicenter cohort of pts hospitalized with COVID-19, 56.6% tx with early empiric abx therapy. Only 3.5% of COVID-19+ pts had confirmed community-onset bacterial co-infect
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @UM_IHPI: NEW work from the #COVID19 data collaborative launched by our members early in the #pandemic: https://t.co/j4Y1RGEI6k
RT @moore_wjustin: Good reminder to practice diagnostic stewardship! 🧐 Ensure those empiric abx are justitifed in patients with COVID, as r…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @UM_IHPI: NEW work from the #COVID19 data collaborative launched by our members early in the #pandemic: https://t.co/j4Y1RGEI6k
RT @UM_IHPI: NEW work from the #COVID19 data collaborative launched by our members early in the #pandemic: https://t.co/j4Y1RGEI6k
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @nbennett04: 💪 work by this group further solidifying the data. Fortunate our physicians continue to trend towards lower abx prescribing…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study | Clinical Infectious Diseases | Oxford Academic https://t.co/XXOUryxHEz
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
Good reminder to practice diagnostic stewardship! 🧐 Ensure those empiric abx are justitifed in patients with COVID, as risk may outweigh benefit ⚖️ Antibiotics are not harmless and should be used judiciously 🦠💊 @SIDPharm @accpinfdprn
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @nbennett04: 💪 work by this group further solidifying the data. Fortunate our physicians continue to trend towards lower abx prescribing…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
#COVID19 and bacterial co-infections! In 38 Michigan hospitals, 57% pt received antibiotics early on Only 3.5% pt had bacterial co-infection, 0.5% viral co-infection https://t.co/cn7JlfoMC8 https://t.co/vdIsKX2MNd
📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx continued, only 7.4% had a confirmed community-onset bacterial co- infection. #IDTwitter
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
💪 work by this group further solidifying the data. Fortunate our physicians continue to trend towards lower abx prescribing based on these publications.
📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 patients had a confirmed community-onset bacterial co-infection. 📍CRO is the most commonly prescribed empiric Ab 📍~26% MRSA ABx 📍~26% PS
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
@BRxAD
Lots of interesting bits in this paper on how we may be able to optimise antibiotic prescriptions in #COVID19. Though was struck by one independent predictor of antibiotics being prescribed - admission to a "For profit" hospital! So grateful not an issue
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ClancyNeil: Bravo! We need more data like these. 3% presented w bacterial co-infection, but majority received abx on admission. @deann…
Bravo! We need more data like these. 3% presented w bacterial co-infection, but majority received abx on admission. @deannabuehrle @AmeshAA @Brookeholderia @mhn5pittedu1 & our team jsut published our experience outside #COVID19 epicentre. We identifie
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with #COVID19 https://t.co/3HUy28O8pj https://t.co/to7mr79Af9